SCHEMBL1290992

SCHEMBL1290992

CN(c1ccccc1-c1ccc2c(c1)Nc1ccc(C(=O)O)cc1NC2=O)S(C)(=O)=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 5/20 0.77
CDK2 P24941 4/20 0.77
CDK5 Q00535 3/20 0.77
CDC42BPA Q5VT25 2/20 0.77
CDK1 P06493 2/20 0.77
SRPK1 Q96SB4 2/20 0.77
SLK Q9H2G2 3/20 0.51
ROCK2 O75116 3/20 0.51
FLT3 P36888 2/20 0.51
MAP4K2 Q12851 2/20 0.51
PDPK1 O15530 1/20 0.51
FES P07332 1/20 0.51
FER P16591 1/20 0.51
MARK3 P27448 1/20 0.51
PKN2 Q16513 1/20 0.51
PIM2 Q9P1W9 1/20 0.51
CHEK1 O14757 11/20 0.48
KDR P35968 3/20 0.46
GSK3A P49840 2/20 0.46
ROCK1 Q13464 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1290852 0.92 IRAK4 (0.77) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1290749 0.92 IRAK4 (0.77) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1290699 0.89 IRAK4 (0.72) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1291013 0.87 IRAK4 (1.00) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1291049 0.86 IRAK4 (0.67) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1291107 0.85 IRAK4 (0.66) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1290962 0.85 IRAK4 (0.66) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1290660 0.85 IRAK4 (0.65) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1290709 0.85 IRAK4 (0.65) IRAK4CDK2CDK5CDC42BPACDK1
SCHEMBL1290868 0.85 IRAK4 (0.81) IRAK4CDK2CDK5CDC42BPACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012045194-A1 BENZODIAZEPINONES AS FAK INHIBITORS FOR TREATMENT OF CANCER ABBOTT LABORATORIES (US) 2012-04-12 WO disclosed